Cited by 38Sirtuins and Resveratrol in MedicineAdipose Tissue and MetabolismPeroxisome Proliferator-Activated Receptors

Resveratrol inhibits the protein expression of transcription factors related adipocyte differentiation and the activity of matrix metalloproteinase in mouse fibroblast 3T3-L1 preadipocytes

Open access
Kang, Nam E, Ha, Ae Wha, Kim, Ji Young, Kim, Woo Kyoung·2012·Nutrition Research and Practice

Abstract

This study attempted to investigate the effects of resveratrol on the differentiation of adipocytes. After cells were treated with various concentrations of resveratrol (0, 10, 20, and 40 µmol/L), adipocyte proliferation, the protein expression of transcription factors, and MMPs' activities were determined. Cell proliferation was inhibited more within 4 days of incubation (P < 0.05), and lipid accumulation in adipocyte was significantly inhibited by 93.8%, 92.4% and 91.5%, respectively, after two days of 10, 20, and 40 µmol/L resveratrol treatment (P < 0.05). Six days of incubation with the three resveratrol concentrations caused a significantly decreases of 63%, 59.9%, and 25.1% GPDH activity as a dose-dependent response. The triglyceride concentration also decreased significantly with the increase of resveratrol concentration (P < 0.05). The protein expression of CCAAT/enhancer-binding protein (C/EBPβ) was decreased significantly by 56% and 30% while PPARγ was significantly reduced by 57% and 15% with resveratrol treatments of 20 and 40 µmol/L, respectively (P < 0.05). The protein expression of C/EBPα was decreased by 83%, 74%, and 38% to increased dosage levels, with significance determined for this decrease from 20 µmol/L of resveratrol. The protein expression of fatty acid binding protein (FABP4) was decreased significantly by 88%, 72%, and 46% with the increase of resveratrol concentration. The activity of MMP-2 was decreased significantly by 84%, 70%, and 63% while MMP-9 activity was decreased significantly by 74%, 62%, and 39% with the increased resveratrol concentrations of 10, 20, and 40 µmol/L, respectively (P < 0.05).

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.4162/nrp.2012.6.6.499

Cites

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Other authors confirmed that resveratrol at dosages 10-40 μM and incubation times 2, 4, and 6 days inhibits pre-adipocyte differentiation, with the greatest inhibition of 40% at 40 μM for 6 days.

    “These findings were confirmed by other authors, who used different dosages (10–40 μM) and incubation times (2, 4, and 6 days). The greatest amount of inhibition of pre-adipocyte differentiation was 40% and was achieved at a dose of 40 μM for 6 days [28].”

    From The Role of Resveratrol Administration in Human Obesity (2021) · cites this paper as [28]

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

The citation lists haven’t been fetched yet

References 39 · Cited by 38

Authors
Kang, N. E., Ha, A. W., Kim, J. Y., & Kim, W. K.
Affiliations
  • Eulji University (KR)
  • Dankook University (KR)
Corresponding author
Kim, Woo Kyoung
Venue
Nutrition Research and Practice
Published
2012
Volume
6
Issue
6
Pages
499
ISSN
  • 1976-1457 (ISSN-L)
  • 2005-6168
OpenAlex
W2119047246
Cited by
38
References
39
Citations by year
2025: 6 · 2024: 1 · 2023: 1 · 2022: 2 · 2021: 3 · 2020: 1 · 2019: 4 · 2018: 1 · 2017: 1 · 2016: 4 · 2015: 3 · 2014: 9 · 2013: 2
FWCI
2.20
Type
journal article
Language
en
Open access
Locations
  • Nutrition Research and Practice (publishedVersion, cc-by-nc)
  • Europe PMC (PubMed Central) (publishedVersion, cc-by-nc)
  • PubMed Central (publishedVersion, cc-by-nc)
  • PubMed (publishedVersion)
Funders
  • Ministry for Food, Agriculture, Forestry and Fisheries (109156-3)
  • Korea Evaluation Institute of Industrial Technology
Topics
  • Health Sciences › Medicine › Geriatrics and Gerontology › Sirtuins and Resveratrol in Medicine
  • Health Sciences › Medicine › Physiology › Adipose Tissue and Metabolism
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Peroxisome Proliferator-Activated Receptors
Keywords
resveratrol, adipogenesis, preadipocytes, 3T3-L1 cells, transcription factors, C/EBPβ, C/EBPα, PPARγ, FABP4, MMP-2, MMP-9, lipid accumulation, triglycerides, adipocyte proliferation

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review